Düsseldorf || 16 - 19 November 2026

Biobeat

Biobeat provides FDA-approved cuffless 24/7 blood pressure monitoring with real-time data.

Therapeutic areas: ·
Company status: Growth Stage
Company profile

Solution at a glance

Biobeat is transforming blood pressure monitoring with FDA-approved, cuffless technology designed for 24/7 monitoring in real-world settings. Unlike traditional cuff-based solutions, Biobeat enables comfortable and non-invasive ambulatory blood pressure monitoring (ABPM), providing valuable insights into blood pressure patterns throughout the day and night. Its wearable technology supports remote patient monitoring and helps healthcare providers identify trends that may be missed by single-point clinic measurements. By combining clinical-grade monitoring, patient comfort, and actionable data, Biobeat enables a more comprehensive understanding of blood pressure and supports better-informed hypertension management.
Meet us at MEDICA 2026

Omer Weissberger

Customer Success and Global Sales Manager
Düsseldorf · 16 – 19 November 2026 · Israel Pavilion

Ready to expand globally?